-

Philadelphia Business Journal Names AscellaHealth President and CEO Dea Belazi Among Top Honorees for Philadelphia Region’s “Most Admired CEOs”

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global specialty pharmacy and healthcare solutions company, announces today that Dea Belazi, president and CEO, will be among the top honorees at the Philadelphia Business Journal’s 2021 “Most Admired CEOs” awards ceremony on Dec. 9, 2021. This award goes to individuals who are established leaders with a strong record of innovation in their field, outstanding financial performance, a commitment to quality, a strong vision, a commitment to diversity in the workplace and contributions to Greater Philadelphia.

“I’m deeply gratified to be honored along with these top business executives and proud of AscellaHealth’s exceptional team that has supported all our corporate initiatives to take a leading position as a Specialty Pharmacy and healthcare services provider,” says Belazi. “In the face of challenges during the pandemic, our goals have remained the same: enhance patient outcomes and expand opportunities to serve key stakeholders throughout the healthcare industry.”

The Philadelphia Business Journal presents this award in recognition of some of the region’s top executives, who have demonstrated the skills, agility and ingenuity required to lead their companies through the most difficult of times. Representing the commercial real estate, engineering, information technology, health care, life sciences and legal industries, along with many other sectors of business, each of these Philadelphia-area chief executives has shown “grit and resilience in navigating the pandemic over the last year,” says representatives from the Philadelphia Business Journal.

“At AscellaHealth, we strive to create a work culture of innovation and collaboration and value the unique contributions that our employees deliver each day,” adds Belazi. “We are committed to achieving health equity for all Americans and understand the importance of promoting greater access to affordable, quality healthcare.”

The Business Journal will recognize these leaders at a live event at the Crystal Tea Room in Philadelphia on Dec. 9 and profile all 28 in a special print edition of the paper on Dec. 10.

About AscellaHealth LLC

AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving payers, providers, life sciences and patients, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. An Inc. 5000 2021 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Visit www.AscellaHealth.com.

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

AscellaHealth


Release Summary
Philadelphia Business Journal Names AscellaHealth President and CEO Dea Belazi Among Top Honorees for Philadelphia Region’s “Most Admired CEOs"
Release Versions

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

More News From AscellaHealth

AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies...

AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies

DUBLIN--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customisable solutions for the specialty pharmaceutical industry, proudly announces its role as Gold Sponsor of the World Orphan Drug Congress Europe (WODC), 22-25 October 2024, Barcelona, Spain. During the event, AscellaHealth will exhibit its comprehensive suite of end-to-end solutions proven to streamline the specialty pharmaceutical commercialisation process for life science manufacturers worldwide. These solutions align wi...

AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Issues Impacting Life Sciences & Payers within the Specialty Healthcare...
Back to Newsroom